Clinical Trials
5
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma Patients
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2008-03-21
- Lead Sponsor
- Critical Therapeutics
- Target Recruit Count
- 36
- Registration Number
- NCT00534625
Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS
- First Posted Date
- 2007-06-14
- Last Posted Date
- 2008-04-03
- Lead Sponsor
- Critical Therapeutics
- Target Recruit Count
- 400
- Registration Number
- NCT00486343
- Locations
- 🇺🇸
Critical Therapeutics, Lexington, Massachusetts, United States
Safety Study of Zileuton Injection in Patients With Asthma
- Conditions
- Asthma
- First Posted Date
- 2006-03-06
- Last Posted Date
- 2007-09-26
- Lead Sponsor
- Critical Therapeutics
- Target Recruit Count
- 60
- Registration Number
- NCT00299065
- Locations
- 🇺🇸
Allergy & Asthma Specialist Medical Group, Huntington Beach, California, United States
🇺🇸Allergy and Asthma Medical Group and Research Center, San Diego, California, United States
🇺🇸Colorado Allergy and Asthma Centers, PC, Englewood, Colorado, United States
CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)
- Conditions
- Heart Valve DiseasesCoronary Disease
- First Posted Date
- 2005-04-07
- Last Posted Date
- 2006-03-17
- Lead Sponsor
- Critical Therapeutics
- Target Recruit Count
- 150
- Registration Number
- NCT00107666
- Locations
- 🇺🇸
Saddleback Memorial Medical Center, Laguna Hills, California, United States
🇺🇸University of Southern California, Los Angeles, California, United States
🇺🇸Kaiser Permanente, San Francisco, California, United States
Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris
- Conditions
- Acne Vulgaris
- First Posted Date
- 2004-12-08
- Last Posted Date
- 2007-02-07
- Lead Sponsor
- Critical Therapeutics
- Target Recruit Count
- 90
- Registration Number
- NCT00098358
- Locations
- 🇺🇸
Therapeutics Clinical Research, San Diego, California, United States
🇺🇸MedaPhase, Inc., Newnan, Georgia, United States
🇺🇸Dermatology Specialists, PSC, Louisville, Kentucky, United States